Business Wire

Sonitor ® Technologies Prepares for Accelerated Growth


Sonitor Technologies AS, the global leader in ultrasound-based, indoor positioning technology, today announced that it will merge its Forkbeard and Sonitor Technologies subsidiaries as it prepares for accelerated revenue growth with the market entry of Forkbeard, the company’s cloud-based, product platform for indoor positioning of smart mobile devices

“We are at the beginning of an exciting new chapter in our company history,” said Arne Oyen, Group President and CEO of Sonitor Technologies AS. “This merger of our subsidiaries strengthens our focus and resources as we expand our global market presence. Forkbeard can deliver the many benefits of indoor positioning and proximity monitoring to every user of a smart phone or tablet. We will build on the strong commercial franchise that Sonitor has established in acute care and senior living with its market leading Sonitor Sense™ platform and expand into other industry sectors, such as manufacturing. Going forward, the merged company will be known as Sonitor, and Forkbeard will be the name of our cloud-based, indoor positioning product platform for mobile devices.”

The sales organizations in Sonitor’s primary geographic markets will offer the full complement of Sonitor Sense and Forkbeard products. Palle Furum will serve as Chief Commercial Officer of Europe and the Middle East (EMEA), and Murray Robinson as Chief Commercial Officer of Asia Pacific (APAC). Both Furum and Robinson have held management positions in their regions with Forkbeard and Sonitor, respectively. Matt Crane, an experienced executive with a successful career in the healthcare industry from start-ups to large corporations, has joined the company to head up North America as Chief Commercial Officer, CEO Sonitor Technologies, Inc.

“We are very pleased to welcome Matt to Sonitor,” Oyen said. “Matt’s background includes 18 years with Hill-Rom in management positions responsible for strategic planning, technical support and sales of medical devices and IT systems such as Nurse Call and RTLS. He has an impressive track record of closing major contracts with top IDNs, the US Government and Group Purchasing Organizations.”

Anne Bugge, who headed Sonitor’s global commercial group for the past eight years, will join the parent company as Strategic Advisor to the Group President and CEO with a focus on building and expanding the company’s key strategic corporate partnerships.

“At Sonitor, we are driven by the spirit of innovation and tackling what others thought was impossible, and have achieved many industry firsts,” Oyen stated. “We have the talent, people, resources and commitment to make a positive contribution through our technology to improve the quality of everyday life.”

About Sonitor

Sonitor Technologies AS is the leading provider and innovator of accurate and reliable ultrasound-based Real Time Location Systems (RTLS) and Indoor Positioning Systems (IPS). It is the first and only company to develop and commercialize proprietary ultrasound technology as the primary technology for indoor positioning of people, equipment, and objects. Sonitor’s product platforms, Sense and Forkbeard, provide location intelligence using advanced algorithms and analytics to improve operational efficiencies, workflow visibility, and personal safety in healthcare and other industry sectors. Visit and for more information.

To view this piece of content from, please give your consent at the top of this page.

Contact information

Dan Conley
Beacon Communications

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

RevBio Launches an Experiment for its Regenerative Biomaterial on the International Space Station9.12.2022 20:04:00 CET | Press release

RevBio, Inc., announced that anexperiment to study Tetranite®, the company’s regenerative bone adhesive biomaterial, has successfully been initiated onboard the International Space Station (ISS). On Saturday, November 26, 2022, the study materials were launched to the space station on SpaceX’s 26th Commercial Resupply Services (SpaceX CRS-26) mission, sponsored by the ISS National Laboratory. This in vivo research, which will be conducted over the next two months on the ISS, will examine the biomaterial’s ability to regenerate bone when used in a microgravity environment where bone growing conditions and the ability to regenerate new bone tissue is significantly compromised. This press release features multimedia. View the full release here: RevBio Launches an Experiment for its Regenerative Biomaterial on the International Space Station. This Experiment will Examine TETRANITE’S Ability to Regenerate Bone under the Condition of

Datopotamab Deruxtecan Showed Promising Responses as Monotherapy and in Combination with Durvalumab in Patients with Metastatic Triple Negative Breast Cancer in Two Early Trials9.12.2022 14:00:00 CET | Press release

Updated results from the TROPION-PanTumor01 phase 1 trial showed datopotamab deruxtecan (Dato-DXd) continued to demonstrate encouraging responses in patients with heavily pretreated metastatic triple negative breast cancer (TNBC) and disease progression following standard treatment. Results were presented today as a poster presentation (Abstract #P6-10-03) at the 2022 San Antonio Breast Cancer Symposium (#SABCS22). Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) being jointly developed by Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN). Approximately 15% of breast cancers are considered triple negative and are associated with higher disease recurrence and worse prognosis compared to other breast cancer subtypes.1,2 It is estimated that only 12% of patients with metastatic TNBC survive five years after diagnosis and median overall survival is between 12 to 18 months.1,3 In the TNBC cohort of TROPION-PanTumor01 (n=44)

Takeda to Present Data at 64th American Society of Hematology (ASH) Annual Meeting, Demonstrating Commitment to Patients with Hematologic Cancers and Other Blood Diseases9.12.2022 14:00:00 CET | Press release

Takeda(TSE:4502/NYSE:TAK) today announced that it will present 15 company-sponsored abstracts at the 64th American Society of Hematology (ASH) Annual Meeting being held December 10-13, 2022 in New Orleans. Takeda’s latest research focuses on improving long-term outcomes for patients with hematologic diseases. Takeda’s presentations will include oral sessions detailing a three-year update of the Phase 3 OPTIC trial demonstrating the efficacy and safety of ICLUSIG® (ponatinib) in patients with resistant chronic-phase chronic myeloid leukemia (CP-CML), and results from a first-in-human Phase 1/2 study evaluating modakafusp alfa (TAK-573) in patients with relapsed / refractory multiple myeloma. “Our latest research is focused on investigating novel mechanisms of action, as well as optimizing approved treatments to improve long-term outcomes and more deeply understand and address unmet needs for patients across a range of hematologic diseases,” said Awny Farajallah, M.D., Head of Global Med

Tecnotree Advances to Acquire Top AIML Platform - CognitiveScale in North America to further Enhance 5G Use case Penetration9.12.2022 13:23:00 CET | Press release

Tecnotree is a market leader in 5G digital Business Support Systems (BSS), with AI/ML capabilities and multi-cloud extensibility. Tecnotree’s global footprint with over 90 Telecom customers in 70 countries around the world, supports ecosystems of over 1 billion subscribers. Tecnotree is the first Digital Platform Service provider to be Platinum Badge Certified by TM Forum for Real-world Open API standards. The company also provides B2B2X partner ecosystem and fintech services for monetization beyond connectivity across gaming, healthcare, education, and banking. Tecnotree has been recognized by Gartner for revenue management and monetization as well as for customer experience management solutions and enjoys the position of a leading stock on the Helsinki Nasdaq since 2020. CognitiveScale (CS) is United States based pioneer in the space of AI Engineering and provides solutions for scalable enterprise AI development and deployment. CognitiveScale is backed by over 100 granted AI patents

Another Sustainability Award for NTHU9.12.2022 10:00:00 CET | Press release

National Tsing Hua University (NTHU) in Taiwan has been awarded the Taiwan University Sustainability Award for the second year in a row! The Award was announced at the 15th Taiwan Corporate Sustainability Awards (TCSA) recently held by the Taiwan Institute for Sustainable Energy (TAISE). Standing out amongst the 47 participating universities, NTHU was ranked first in the comprehensive evaluation, and in the individual competitions received the University Sustainability Report Gold Award. This press release features multimedia. View the full release here: NTHU president W. John Kao (right) accepting the Taiwan University Sustainability Award from You Si-kun, president of the Legislative Yuan. (Photo: National Tsing Hua University) The judges cited the exemplary way in which NTHU has adopted an innovative approach to integrating classroom learning, campus activities and social service, thereby enriching students’ education and cre